270) However, the pharmacokinetic studies revealed no significant difference |
271) Histopathological studies revealed that BM protected the neu |
272) Moreover, in vitro studies revealed that activity of both scr |
273) Recent studies revealed that microRNAs (miRNAs) w |
274) In vitro studies revealed that osteoblasts grown on |
275) Electrophysiological studies revealed that some animals in the |
276) Histopathological studies revealed that the number of osteoc |
277) Recent studies revealed time-dependent consolidat |
278) However, there are no studies that had quantitatively compared t |
279) In the current paper, we review studies that have employed EBC as a biomar |
280) essment policy-based literature review of studies that have looked at URVs presentin |
281) and EMBASE (to April 2011) and retrieved studies that investigated the relationship |
282) rement in cases of exceptionally valuable studies that involve subjects who can give |
283) Finally, we review studies that propose production strategies |
284) In all, 19 eligible studies that reported odds ratios and 95% |
285) ommendations from the major societies and studies that support early and aggressive |
286) Ridley's studies using cadavers executed by hanging |
287) quently confirmed by dozens of subsequent studies using data from DNA sequences. |
288) Our previous studies using fMRI have demonstrated that |
289) that may guide hypothesis generation for studies using other imaging modalities. |
290) Mechanistic studies using rat everted gut sac model re |
291) osity, drug content and ex vivo diffusion studies using rat skin. |
292) We performed a meta-analysis of 13 studies using the Comprehensive Meta-Analy |
293) et been realized and no long-term in vivo studies using zonal chondrocytes have been |
294) Studies with murine models suggest that ma |
295) More well-designed studies with a larger sample size and long |
296) Improvements were observed in studies with and without cooling-induced p |
297) ancy increases the risk for SGA; however, studies with greater statistical power are |
298) y applied standard methods, especially in studies with high non-compliance due to ch |
299) ce weighting to provide greater weight to studies with larger sample size and more p |
300) Further studies with longitudinal observations are |
301) thods for assessing power in longitudinal studies with missing data, the impact on p |
302) Further prospective studies should be designed to elucidate th |
|